BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32247587)

  • 1. Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma.
    Rykina-Tameeva N; Nahm CB; Mehta S; Gill AJ; Samra JS; Mittal A
    HPB (Oxford); 2020 Nov; 22(11):1631-1636. PubMed ID: 32247587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
    Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
    Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
    Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
    J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
    Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
    Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
    Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis.
    Kamarajah SK; Bundred JR; Boyle C; Oo J; Pandanaboyana S; Loveday B
    ANZ J Surg; 2020 Nov; 90(11):2201-2210. PubMed ID: 32418344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased postoperative pancreatic fistula rate after distal pancreatectomy compared with pancreatoduodenectomy is attributable to a difference in acinar scores.
    Nahm CB; Alzaabi S; Sahni S; Gill AJ; Samra JS; Mittal A
    J Hepatobiliary Pancreat Sci; 2021 Jun; 28(6):533-541. PubMed ID: 33665934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of margin histology on development of pancreatic fistula following pancreatoduodenectomy.
    Harrell KN; Jajja MR; Postlewait LM; Memis B; Maithel SK; Sarmiento JM; Adsay NV; Kooby DA
    J Surg Res; 2020 Feb; 246():315-324. PubMed ID: 29754962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
    Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
    Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinar content at pancreatic resection margin is significantly associated with clinically relevant pancreatic fistula after partial pancreatoduodenectomy.
    Mintziras I; Görg M; Wächter S; Manoharan J; Albers MB; Maurer E; Kanngiesser V; Jesinghaus M; Bartsch DK
    J Gastrointest Surg; 2024 Mar; 28(3):252-258. PubMed ID: 38445917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach.
    Hyman DW; Almerey T; Mujkanovic A; Hammons I; Tice M; Stauffer JA
    Am Surg; 2022 Aug; 88(8):1868-1874. PubMed ID: 35465681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
    Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
    J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy.
    Partelli S; Andreasi V; Schiavo Lena M; Rancoita PMV; Mazza M; Mele S; Guarneri G; Pecorelli N; Crippa S; Tamburrino D; Doglioni C; Falconi M
    Surgery; 2021 Oct; 170(4):1215-1222. PubMed ID: 33933282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas-visceral fat CT value ratio and serrated pancreatic contour are strong predictors of postoperative pancreatic fistula after pancreaticojejunostomy.
    Kusafuka T; Kato H; Iizawa Y; Noguchi D; Gyoten K; Hayasaki A; Fujii T; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    BMC Surg; 2020 Jun; 20(1):129. PubMed ID: 32527310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.
    Callery MP; Pratt WB; Kent TS; Chaikof EL; Vollmer CM
    J Am Coll Surg; 2013 Jan; 216(1):1-14. PubMed ID: 23122535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula.
    Nahm CB; Brown KM; Townend PJ; Colvin E; Howell VM; Gill AJ; Connor S; Samra JS; Mittal A
    HPB (Oxford); 2018 May; 20(5):432-440. PubMed ID: 29307511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis.
    Machairas N; Raptis DA; Velázquez PS; Sauvanet A; Rueda de Leon A; Oba A; Koerkamp BG; Lovasik B; Chan C; Yeo CJ; Bassi C; Ferrone CR; Kooby D; Moskal D; Tamburrino D; Yoon DS; Barroso E; de Santibañes E; Kauffmann EF; Vigia E; Robin F; Casciani F; Burdío F; Belfiori G; Malleo G; Lavu H; Hartog H; Hwang HK; Han HS; Marques HP; Poves I; Domínguez-Rosado I; Park JS; Lillemoe KD; Roberts K; Sulpice L; Besselink MG; Abuawwad M; Del Chiaro M; de Santibañes M; Falconi M; D'Silva M; Silva M; Hilal MA; Qadan M; Sell NM; Beghdadi N; Napoli N; Busch ORC; Mazza O; Muiesan P; Müller PC; Ravikumar R; Schulick R; Powell-Brett S; Abbas SH; Mackay TM; Stoop TF; Gallagher TK; Boggi U; van Eijck C; Clavien PA; Conlon KCP; Fusai GK
    Ann Surg; 2021 Nov; 274(5):721-728. PubMed ID: 34353988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic pancreaticoduodenectomy reduces incidence of clinically relevant postoperative pancreatic fistula in soft pancreas with a smaller than 2 mm pancreatic duct.
    Hong SS; Chong JU; Hwang HK; Lee WJ; Kang CM
    Surg Endosc; 2021 Dec; 35(12):7094-7103. PubMed ID: 33398573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.
    Nahm CB; Lui I; Naidoo CS; Roseverne L; Alzaabi S; Maher R; Mann G; Blome S; Gill AJ; Samra JS; Mittal A
    HPB (Oxford); 2019 May; 21(5):604-611. PubMed ID: 30377050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
    Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.